Viracta Therapeutics, Inc. (VIRX)
USD 0.21
(-4.22%)
USD 0.21
(-4.22%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | -39.89 Million | -35.45 Million | -18.85 Million | -16.05 Million | -22.18 Million | -24.4 Million |
| Net Income | -51.05 Million | -49.19 Million | -114.76 Million | -19.01 Million | -23.33 Million | -26.61 Million |
| Depreciation & Amortization | 492 Thousand | 210 Thousand | 178 Thousand | 32 Thousand | 3135.00 | 9000.00 |
| Deferred income taxes | 98 Thousand | - | 290 Thousand | - | -602.63 Thousand | - |
| Stock-based compensation | 7.64 Million | 13.54 Million | 5.54 Million | 348 Thousand | 627.61 Thousand | 210.59 Thousand |
| Change in working capital | 5.07 Million | 608 Thousand | 1.68 Million | 2.57 Million | -650 Thousand | -627 Thousand |
| Other non-cash items | -2.15 Million | -626 Thousand | 88.22 Million | 12 Thousand | 2.39 Million | 3.15 Million |
| Investing Cash Flow | 14.99 Million | -53.86 Million | 12.89 Million | -55 Thousand | -16.28 Million | 4.78 Million |
| Investments in PPE | -138 Thousand | -45 Thousand | -4.25 Million | -55 Thousand | - | - |
| Acquisitions | -15.13 Thousand | - | 17.14 Million | - | - | - |
| Investment purchases | -67.13 Million | -70.62 Million | - | -747 Thousand | -20.03 Million | - |
| Sales/Maturities of investments | 82.27 Million | 16.79 Million | - | 17.15 Million | 3.75 Million | 4.78 Million |
| Other Investing Activities | 15.13 Thousand | - | 13.14 Million | -16.4 Million | - | - |
| Financing Cash Flow | 438 Thousand | 22.54 Million | 62.42 Million | 44.98 Million | 43.03 Million | 6.34 Million |
| Debt repayment | - | -19.98 Million | -234 Thousand | -44.13 Million | -2.04 Million | - |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | 438 Thousand | 2.33 Million | 62.32 Million | 851 Thousand | 45.08 Million | 6.34 Million |
| Other Financing Activities | 139 Thousand | 40.19 Million | 339 Thousand | 88.26 Million | 24.58 Million | 6.89 Million |
| Accounts receivables | - | - | - | - | - | - |
| Accounts payables | -98 Thousand | -361 Thousand | 922 Thousand | 969 Thousand | -602 Thousand | -304 Thousand |
| Inventory | - | - | - | - | - | - |
| Other working capital | 5.17 Million | 969 Thousand | 758 Thousand | 1.6 Million | -48 Thousand | -323 Thousand |
| Cash at beginning of period | 36.77 Million | 103.55 Million | 47.08 Million | 18.21 Million | 13.69 Million | 26.97 Million |
| Cash at end of period | 12.31 Million | 36.77 Million | 103.55 Million | 47.08 Million | 18.26 Million | 13.69 Million |
| Capital Expenditure | -138 Thousand | -45 Thousand | -4.25 Million | -55 Thousand | - | - |
| Effect of forex changes on cash | - | - | - | - | -4.55 Million | - |
| Net cash flow / Change in cash | -24.45 Million | -66.78 Million | 56.46 Million | 28.87 Million | 4.56 Million | -13.28 Million |
| Free Cash Flow | -40.03 Million | -35.5 Million | -23.1 Million | -16.1 Million | -22.18 Million | -24.4 Million |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -9.83 Million | -9.14 Million | -51.05 Million | -13.76 Million | -12.6 Million | -12.48 Million |
| Depreciation & Amortization | 96 Thousand | 110 Thousand | 492 Thousand | 123 Thousand | 128 Thousand | 119 Thousand |
| Deferred income taxes | - | - | 98 Thousand | -1.95 Million | - | - |
| Stock-based compensation | 1.37 Million | 1.83 Million | 7.64 Million | 1.78 Million | 1.77 Million | 1.97 Million |
| Change in working capital | -1.24 Million | -318 Thousand | 5.07 Million | 2.3 Million | 679 Thousand | 2.93 Million |
| Other non-cash items | 2.47 Million | 1.75 Million | -2.15 Million | 1.47 Million | -518 Thousand | -538 Thousand |
| Investing Cash Flow | 11.7 Million | 14.19 Million | 14.99 Million | 9.27 Million | 9.09 Million | 3.98 Million |
| Investments in PPE | 9.82 Million | - | -138 Thousand | - | 51 Thousand | -189 Thousand |
| Acquisitions | - | - | -15.13 Thousand | -179.95 Thousand | -9047.00 | 189 Thousand |
| Investment purchases | -3.58 Million | -6.05 Million | -67.13 Million | -7.48 Million | -18.2 Million | -13.83 Million |
| Sales/Maturities of investments | 15.28 Million | 20.24 Million | 82.27 Million | 16.75 Million | 27.25 Million | 18 Million |
| Other Investing Activities | - | 14.19 Million | 15.13 Thousand | 9270.00 | 9047.00 | -189 Thousand |
| Financing Cash Flow | 43 Thousand | -6.59 Million | 438 Thousand | 218 Thousand | - | 204 Thousand |
| Debt repayment | -1000.00 | -6.67 Million | - | - | - | - |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | 44 Thousand | 80 Thousand | 438 Thousand | 218 Thousand | - | 127 Thousand |
| Other Financing Activities | 44 Thousand | 80 Thousand | 139 Thousand | 218.00 | - | 77 Thousand |
| Accounts receivables | - | - | - | - | - | - |
| Accounts payables | -1.12 Million | -30 Thousand | -98 Thousand | 80 Thousand | -873 Thousand | 1.15 Million |
| Inventory | - | - | - | - | - | - |
| Other working capital | -121 Thousand | -288 Thousand | 5.17 Million | 2.22 Million | 1.55 Million | 1.78 Million |
| Cash at beginning of period | 12.06 Million | 12.31 Million | 36.77 Million | 12.85 Million | 14.29 Million | 18.09 Million |
| Cash at end of period | 13.98 Million | 12.06 Million | 12.31 Million | 12.31 Million | 12.85 Million | 14.29 Million |
| Capital Expenditure | 9.82 Million | - | -138 Thousand | - | 51 Thousand | -189 Thousand |
| Effect of forex changes on cash | - | - | - | - | - | - |
| Net cash flow / Change in cash | 1.91 Million | -255 Thousand | -24.45 Million | -539 Thousand | -1.43 Million | -3.8 Million |
| Free Cash Flow | - | -7.84 Million | -40.03 Million | -10.02 Million | -10.48 Million | -8.17 Million |
0R1B
0LDR
6995
4246
002696
NIRAJ